RLAY Q2 2021 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$844,000

Gross Profit

-$44M-5249.2% margin

Operating Income

-$194M-22936.0% margin

Net Income

-$193M-22914.6% margin

EPS (Diluted)

$-2.10

QoQ Revenue Growth

-11.3%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$714M

Total Liabilities

$96M

Stockholders' Equity

$619M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$844,000	$0	—
Gross Profit	-$44M	$0	—
Operating Income	-$194M	-$28M	-598.4%
Net Income	-$193M	-$27M	-623.7%